precirol has been researched along with zanamivir in 1 studies
| Studies (precirol) | Trials (precirol) | Recent Studies (post-2010) (precirol) | Studies (zanamivir) | Trials (zanamivir) | Recent Studies (post-2010) (zanamivir) |
|---|---|---|---|---|---|
| 81 | 0 | 52 | 1,168 | 85 | 546 |
| Protein | Taxonomy | precirol (IC50) | zanamivir (IC50) |
|---|---|---|---|
| Chain A, Neuraminidase | Influenza B virus (STRAIN B/BEIJING/1/87) | 0.004 | |
| Chain A, Neuraminidase | Influenza B virus (STRAIN B/BEIJING/1/87) | 0.004 | |
| Chain A, Neuraminidase | Influenza A virus | 0.004 | |
| Neuraminidase | Influenza A virus (A/Turkey/651242/2006(H5N1)) | 0.0054 | |
| Neuraminidase | Influenza A virus (A/Wilson-Smith/1933(H1N1)) | 0.0364 | |
| Neuraminidase | Influenza A virus (A/duck/Laos/25/2006(H5N1)) | 0.0027 | |
| Neuraminidase | Influenza A virus (A/Brisbane/59/2007(H1N1)) | 0.0276 | |
| Neuraminidase | Influenza A virus (A/Puerto Rico/8/1934(H1N1)) | 0.0043 | |
| Neuraminidase | Influenza A virus (A/Wilson-Smith/1933(H1N1)) | 0.0017 | |
| Neuraminidase | Influenza A virus (A/Memphis/1/1971(H3N2)) | 0.0147 | |
| Neuraminidase | Influenza B virus (B/Lee/1940) | 0.0809 | |
| Neuraminidase | Influenza A virus (A/udorn/1972(H3N2)) | 0.0154 | |
| Acyl-CoA desaturase 1 | Mus musculus (house mouse) | 0.001 | |
| Neuraminidase | Influenza B virus (STRAIN B/VICTORIA/3/85) | 0.0045 | |
| Histamine H1 receptor | Cavia porcellus (domestic guinea pig) | 0.0077 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0074 | |
| Neuraminidase | Influenza A virus (A/duck/Ukraine/1/1963(H3N8)) | 0.0074 | |
| Neuraminidase | Influenza A virus (A/RI/5+/1957(H2N2)) | 1.4 | |
| Neuraminidase | Influenza A virus (A/udorn/1972(H3N2)) | 0.0229 | |
| Neuraminidase | Influenza A virus (A/chicken/Yogjakarta/BBVet-IX/2004(H5N1)) | 0.0007 | |
| Neuraminidase | Influenza B virus (B/Perth/211/2001) | 0.0882 | |
| Neuraminidase | Influenza A virus (A/Thailand/1(KAN-1)/2004(H5N1)) | 0.0024 | |
| Neuraminidase | Influenza A virus (A/Singapore/1/1957(H2N2)) | 0.007 | |
| Neuraminidase | Influenza A virus (A/budgerigar/Hokkaido/1/1977(H4N6)) | 0.0228 | |
| Neuraminidase | Influenza A virus (A/Aichi/2/1968(H3N2)) | 0.0027 | |
| Integrase | Human immunodeficiency virus 1 | 0.0025 | |
| Sialidase-3 | Homo sapiens (human) | 5.6617 | |
| Sialidase-2 | Homo sapiens (human) | 6.7333 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, QR; Cao, Y; Cui, JH; Shi, LL; Zhu, XY | 1 |
1 other study(ies) available for precirol and zanamivir
| Article | Year |
|---|---|
Optimization of process variables of zanamivir-loaded solid lipid nanoparticles and the prediction of their cellular transport in Caco-2 cell model.
Topics: Antiviral Agents; Biological Transport; Caco-2 Cells; Cell Survival; Diglycerides; Drug Liberation; Fatty Acids; Glycerides; Humans; Microscopy, Electron, Transmission; Nanoparticles; Poloxamer; Polyvinyl Alcohol; Solubility; Spectroscopy, Fourier Transform Infrared; Surface-Active Agents; X-Ray Diffraction; Zanamivir | 2015 |